News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
207,650 Results
Type
Article (34534)
Company Profile (41)
Press Release (173075)
Multimedia
Podcasts (6)
Webinars (9)
Section
Business (59693)
Career Advice (432)
Deals (5337)
Drug Delivery (14)
Drug Development (27191)
Employer Resources (50)
FDA (3840)
Job Trends (3922)
News (94088)
Policy (5267)
Tag
Academia (2431)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (24)
Alliances (12842)
ALS (32)
Alzheimer's disease (604)
Antibody-drug conjugate (ADC) (32)
Approvals (3861)
Artificial intelligence (79)
Autoimmune disease (4)
Automation (8)
Bankruptcy (37)
Best Places to Work (3066)
BIOSECURE Act (5)
Biosimilars (9)
Biotechnology (34)
Bladder cancer (26)
Brain cancer (10)
Breast cancer (102)
Cancer (753)
Cardiovascular disease (47)
Career advice (393)
Career pathing (10)
CAR-T (50)
Cell therapy (133)
Cervical cancer (7)
Clinical research (21169)
Collaboration (225)
Company closure (1)
Compensation (60)
Complete response letters (1)
COVID-19 (1236)
CRISPR (21)
C-suite (173)
Cystic fibrosis (42)
Data (910)
Decentralized trials (1)
Denatured (4)
Depression (8)
Diabetes (65)
Diagnostics (1861)
Digital health (2)
Diversity (5)
Diversity, equity & inclusion (15)
Drug discovery (28)
Drug pricing (10)
Drug shortages (1)
Duchenne muscular dystrophy (26)
Earnings (9199)
Editorial (7)
Employer branding (8)
Employer resources (42)
Events (29215)
Executive appointments (501)
FDA (4161)
Frontotemporal dementia (4)
Funding (260)
Gene editing (48)
Generative AI (4)
Gene therapy (96)
GLP-1 (162)
Government (1043)
Guidances (21)
Healthcare (5982)
Huntington's disease (3)
IgA nephropathy (9)
Immunology and inflammation (19)
Indications (10)
Infectious disease (1272)
Inflammatory bowel disease (48)
Inflation Reduction Act (1)
Influenza (17)
Intellectual property (23)
Interviews (53)
IPO (2630)
IRA (6)
Job creations (942)
Job search strategy (365)
Kidney cancer (6)
Labor market (13)
Layoffs (84)
Leadership (2)
Legal (1131)
Liver cancer (21)
Lung cancer (98)
Lymphoma (50)
Machine learning (3)
Management (12)
Manufacturing (58)
MASH (32)
Medical device (3626)
Medtech (3627)
Mergers & acquisitions (2823)
Metabolic disorders (156)
Multiple sclerosis (22)
NASH (5)
Neurodegenerative disease (30)
Neuropsychiatric disorders (3)
Neuroscience (766)
NextGen: Class of 2025 (2085)
Non-profit (1866)
Now hiring (13)
Obesity (60)
Opinion (35)
Ovarian cancer (42)
Pain (18)
Pancreatic cancer (32)
Parkinson's disease (49)
Partnered (5)
Patents (46)
Patient recruitment (39)
Peanut (13)
People (34305)
Pharmaceutical (7)
Pharmacy benefit managers (1)
Phase I (6831)
Phase II (9690)
Phase III (6398)
Pipeline (290)
Policy (27)
Postmarket research (1060)
Preclinical (3605)
Press Release (27)
Prostate cancer (30)
Psychedelics (9)
Radiopharmaceuticals (102)
Rare diseases (128)
Real estate (1799)
Recruiting (24)
Regulatory (3613)
Reports (5)
Research institute (1413)
Resumes & cover letters (34)
Rett syndrome (2)
RNA editing (2)
RSV (1)
Schizophrenia (14)
Series A (49)
Series B (26)
Service/supplier (1)
Sickle cell disease (21)
Spinal muscular atrophy (43)
Sponsored (8)
Startups (1429)
Stomach cancer (2)
Supply chain (3)
Tariffs (7)
The Weekly (2)
Vaccines (224)
Venture capitalists (5)
Weight loss (27)
Women's health (7)
Worklife (3)
Date
Last 7 days (221)
Last 30 days (790)
Last 365 days (9112)
2025 (3228)
2024 (9802)
2023 (12099)
2022 (14820)
2021 (16113)
2020 (15233)
2019 (14543)
2018 (10784)
2017 (10185)
2016 (10546)
2015 (12358)
2014 (9322)
2013 (8900)
2012 (8991)
2011 (8855)
2010 (7942)
Location
Africa (285)
Alabama (17)
Alaska (3)
Arizona (41)
Arkansas (7)
Asia (11648)
Australia (2846)
California (1683)
Canada (523)
China (129)
Colorado (64)
Connecticut (74)
Delaware (34)
Europe (31785)
Florida (180)
Georgia (60)
Idaho (12)
Illinois (137)
India (3)
Indiana (72)
Iowa (3)
Japan (57)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (14)
Maryland (180)
Massachusetts (2447)
Michigan (45)
Minnesota (86)
Mississippi (1)
Missouri (23)
Montana (10)
Nebraska (4)
Nevada (17)
New Hampshire (10)
New Jersey (439)
New Mexico (9)
New York (470)
North Carolina (290)
North Dakota (2)
Northern California (803)
Ohio (74)
Oklahoma (7)
Oregon (10)
Pennsylvania (318)
Puerto Rico (2)
Rhode Island (12)
South America (327)
South Carolina (4)
Southern California (626)
Tennessee (26)
Texas (230)
United States (7103)
Utah (49)
Virginia (36)
Washington D.C. (19)
Washington State (157)
West Virginia (1)
Wisconsin (12)
207,650 Results for "boston university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boston Scientific announces upcoming investor conference schedule
May 2, 2025
·
1 min read
Press Releases
Boston Scientific announces results for first quarter 2025
April 23, 2025
·
19 min read
Press Releases
AI Proteins to Present Key Advances in Miniprotein Therapeutics Development at PEGS Boston 2025
May 6, 2025
·
2 min read
Press Releases
VectorY Therapeutics to Present Preclinical Data on Novel ALS Therapeutic Strategy at Target ALS Conference in Boston
May 7, 2025
·
3 min read
Press Releases
XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston
April 29, 2025
·
3 min read
MASH
Boston Pharma Carves Out Monthly Treatment Niche in MASH With Strong Phase II Data
Boston Pharma’s once-monthly injection efimosfermin alfa offers a convenient dosing option for MASH patients while also achieving promising rates of fibrosis and MASH improvement, according to a Phase II readout.
November 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Boston Pharmaceuticals to Present the Effect of Efimosfermin Alfa on Collagen Biomarkers in Patients with F2 and F3 MASH at EASL Congress 2025
April 28, 2025
·
6 min read
Press Releases
Boston Scientific announces conference call discussing first quarter 2025 results
April 1, 2025
·
1 min read
Press Releases
Boston Scientific announces agreement to acquire SoniVie Ltd.
March 4, 2025
·
7 min read
Press Releases
Boston Pharmaceuticals to Present State-of-the-Art Lecture and Poster for Once-monthly Efimosfermin Alfa at Digestive Disease Week® 2025
April 23, 2025
·
7 min read
1 of 20,765
Next
